0 items USD 0.00Search
- Did you mean
- crohn diseases
Your search for "Crohn’s disease" gave back 100519 results.
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
October 2023
Price: USD 2,900.00
Intercellular Adhesion Molecule 1 - Pipeline Review, H2 2019 Summary Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
August 2019
Price: USD 3,500.00
The global Smart Pill Technologies market size was valued at US$ million in 2023. With growing demand in downstream market, the Smart Pill...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
November 2024
Price: USD 3,660.00
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2018 Summary Integrin Alpha 4 (...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
January 2018
Price: USD 3,500.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
April 2024
Price: USD 2,900.00
The global Tysabri market size was valued at US$ 1986.7 million in 2023. With growing demand in downstream market, the Tysabri is forecast to a...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019 Summary Intercellular Adhesion...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
March 2019
Price: USD 3,500.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
Global Â鶹Դ´s Direct
December 2021
Price: USD 3,500.00
The global Natalizumab Drug market size was valued at US$ 1986.7 million in 2023. With growing demand in downstream market, the Natalizumab Drug is...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
The global Tysabri Drugs market size was valued at US$ 1986.7 million in 2023. With growing demand in downstream market, the Tysabri Drugs is...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
The global Tysabri (natalizumab) Drug market size was valued at US$ 1986.7 million in 2023. With growing demand in downstream market, the Tysabri (...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
The global Inflammatory Bowel Disease Therapy market size was valued at US$ 16900 million in 2023. With growing demand in downstream market, the...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
September 2024
Price: USD 3,660.00
The global Certolizumab Pegol market size was valued at US$ million in 2023. With growing demand in downstream market, the Certolizumab Pegol is...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
December 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
July 2024
Price: USD 4,900.00
Ìý
Filter By Report Date
Filter By Industry
Filter By Country
- Global (100072) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Â鶹Դ´s (1) Apply Emerging Â鶹Դ´s filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
